1Silva J, Garcia JM, Pena C, et al. Implication of polycomb members Bmi-1 ,Mel-18 ,and Hpc-2 in the regulation of p16INK4A, p14ARF, hTERT, and c-Myc expression in primary breast carcinomas[ J]. Clin Cancer Res,2006,12 (23) :6929 - 6936.
6Silva J, Garcia V, Garcia JM, et al. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients [ J ]. Breast Cancer Res. 2007,9(4) :R55.
7Bea S, Tort F, Pinyol M, et al. Bmi-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas[ J]. Cancer Res,2001,61 (6) :2409 - 2412.
8Kemenade FJ, van Raaphorst FM, Blokzijl T, et al. Coexpression of Bmi-1 and EZH2 polyeomb group protein is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma[ J]. Blood,2001,97(12) :3896 - 3901.
6Jacobs JL,Scheijen B,Vonken JW,et al.Bmi-1 collaborates with c-myc in tumorigenesis by inhibiting c-myc-induced apoptosis via INK4A/ARF[J].Genes Dev,1999,3(9):2678-2690
7Park I.-K.,Qian D,Kiel M,et al.Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells[J].Nature,2003,423(6937):302-305.
9Muhammad AH,Michael BW,Max W,et al.Therapeutic implication of cancer stem cells[J].Curr Opin Genet Dev,2004,14(1):43-47.
10Blair A,Hogge DE,Allies LE,et al.Lack of expression of thy-1(CD90)on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo[J].Blood,1997,89(9):3104-3112.
